Vineet Laboratories Limited (NSE:VINEETLAB)

Market Cap	630.54M +33.2%
Revenue (ttm)	560.13M -43.4%
Net Income	-101.39M
EPS	-11.04
Shares Out	19.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,435
Average Volume	75,233
Open	33.00
Previous Close	32.83
Day's Range	31.02 - 33.25
52-Week Range	26.51 - 49.99
Beta	-0.15
RSI	49.70
Earnings Date	Jan 22, 2026

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl th...

• Industry: Chemicals
• Sector: Materials
• Founded: 2016
• Employees: 57
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VINEETLAB